Cargando…
Toripalimab-associated diabetes mellitus: a case report from the community of Southern China
SUMMARY: Immune checkpoint inhibitors (ICPis) are novel immunotherapy drugs for a variety of cancers. Toripalimab is one of the ICPis that selectively blocks programmed death 1 (PD-1) and has been used for the treatment of malignant cancers in the hospitals of China. But with the widespread use of I...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bioscientifica Ltd
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337247/ https://www.ncbi.nlm.nih.gov/pubmed/37341461 http://dx.doi.org/10.1530/EDM-22-0387 |